Translational Genomics

Most would agree that complex cardiovascular diseases such as atherosclerosis result from the interaction between one’s inherent genetic makeup and environmental factors such as smoking, exercise and diet.

 

The primary goal of our laboratory is to identify the genes that contribute to cardiovascular disease using genomic technologies such as microarray and metabolomic analyses. By combining information from studies of both human and animals, we hope to distill the massive amounts of data derived from these high-throughput techniques. Our primary areas of interest include atherosclerosis, acute heart failure and atrial fibrillation.